Journal
EXPERT REVIEW OF ANTICANCER THERAPY
Volume 9, Issue 3, Pages 293-302Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.9.3.293
Keywords
altered fractionation; biologic therapy; chemotherapy; head and neck cancer; organ preservation; radiation therapy
Categories
Ask authors/readers for more resources
Head and neck cancer is best managed in a multidisciplinary setting. Surgery, radiation therapy, chemotherapy and, more recently, biologic therapy are often employed in various combinations in an attempt to eradicate both clinically apparent and occult disease. The goals of treatment include maximizing tumor control while maintaining function and quality of life. Most patients present with locally advanced disease, and multimodality organ-conserving therapy is often employed for these patients based on the results of multiple Phase III clinical trials. This article focuses on the rationale and evidence supporting the use of concurrent chemotherapy and radiation therapy in the management of locally advanced head and neck cancers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available